Brainomix 360 Triage LVO

by Brainomix Limited  · Based in United Kingdom → — AI-Enabled Precision. We turn ordinary scans into extraordinary insights, enabling precision medicine for better treatment decisions.
Emergency Medicine Neurology Radiology
Website
Claim this tool
Is this the maker? Claim the company →

Contact for pricing
Regulatory Status Disclosed

Overview

Brainomix Limited specializes in the creation of AI-powered medical imaging software solutions designed to enable precision medicine for disease assessment and treatment, with a primary focus on stroke, lung disease, and cancer. The company’s flagship platform, Brainomix 360, aims to optimize workflow across stroke networks and facilitate faster treatment and transfer decisions.

Brainomix 360 Triage LVO is a specific module within this platform, functioning as an FDA-cleared notification tool. It provides real-time alerts of suspected large vessel occlusion (LVO) directly to clinicians’ smartphones. This AI-powered tool evaluates occlusions of the intracranial internal carotid artery (ICA) and the proximal middle cerebral artery (M1 segment) on CT angiography scans, offering basic image viewing functions through various output formats. The presence of LVO is a critical factor in determining the best course of treatment for stroke patients, including eligibility for mechanical thrombectomy.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Real-time alerts for suspected Large Vessel Occlusion (LVO)
  • AI-powered analysis of CT angiography (CTA) scans
  • Evaluates occlusions of intracranial internal carotid artery (ICA) and proximal middle cerebral artery (M1 segment)
  • Delivers notifications directly to clinicians' smartphones
  • Supports faster treatment and transfer decisions in stroke networks
  • Provides basic image viewing functions through multiple output formats
  • Part of the comprehensive Brainomix 360 platform
  • DICOM processing and job management
  • Web user interface for accessing notifications and straightened images

Use Cases

  • Triage and notification of suspected LVO in acute stroke patients
  • Supporting clinical decision-making for mechanical thrombectomy eligibility
  • Optimizing workflow and communication across stroke networks
  • Facilitating faster treatment and transfer decisions for stroke patients
  • Enabling remote access to critical imaging results for physicians
  • Assisting both specialist and non-specialist centers with treatment and transfer decisions

What Physicians Need to Know

Stroke Detection Speed
Brainomix 360 Triage LVO provides real-time alerts for suspected large vessel occlusion, designed to optimize workflow and facilitate faster treatment and transfer decisions for stroke patients. Studies have shown that the Brainomix 360 Stroke platform, which includes Triage LVO, can reduce door-in-door-out times by over one hour and increase mechanical thrombectomy rates.
Brain CT Analysis
The AI-powered tool evaluates occlusions of the intracranial internal carotid artery (ICA) and proximal middle cerebral artery (M1 segment) on CT angiography (CTA) scans. The broader Brainomix 360 Stroke platform also analyzes non-contrast CT (NCCT) images for large vessel occlusion (LVO) suspicion using ASPECTS and hyperdense vessel sign (HDVS) algorithms, and can assess intracranial hemorrhage (ICH).
Large Vessel Occlusion Detection
Brainomix 360 Triage LVO is an FDA-cleared notification tool specifically designed to provide real-time alerts of suspected large vessel occlusion (LVO) to clinicians. It evaluates CTA scans for LVOs in the intracranial ICA and M1 segment. The Triage Stroke module also identifies suspected LVO on NCCT.
Triage Prioritization Speed
The system is built to provide real-time alerts and notifications, enabling rapid identification and communication of critical findings to specialists. This parallel workflow tool assists hospital networks in prioritizing cases and facilitating faster treatment and transfer decisions.
ASPECTS Score Automation
While 'Triage LVO' is primarily a notification tool, the broader Brainomix 360 Stroke platform includes the 'e-ASPECTS' module, which automatically assesses the ASPECTS score and infarct volume on non-contrast CT images, with overlaid heatmaps for visual aid. The Triage Stroke module also incorporates ASPECTS in its LVO suspicion algorithm.
Mobile Notification System
Brainomix 360 Triage LVO sends real-time alerts of suspected LVO directly to clinicians' smartphones. Notifications can be accessed via a mobile application or web user interface, allowing for preview of compressed images for informational purposes.
Physician Tip

Brainomix 360 Triage LVO is a valuable tool for expediting the identification and notification of suspected large vessel occlusions in acute stroke patients. Physicians should leverage the real-time mobile alerts to quickly prioritize cases requiring urgent intervention, such as mechanical thrombectomy. While the mobile app provides compressed preview images for rapid assessment, definitive diagnostic interpretation should always be performed on full-resolution images within the standard PACS or viewing system. Integrate this tool into existing stroke protocols to streamline communication across stroke networks and facilitate faster decision-making for treatment and patient transfer.

Brainomix 360 Triage LVO operates within the integrated Brainomix 360 Platform, which is compliant with the DICOM standard. It integrates into existing patient pathways as a parallel workflow tool, processing images and sending notifications independent of standard image interpretation. Results can be delivered to PACS, email notifications, and mobile apps/web UI, ensuring broad accessibility within a hospital network. The platform is designed to optimize workflow across stroke networks and facilitate faster treatment and transfer decisions.

Details

Category Neurology AI, Radiology & Imaging AI, Triage & ER/ICU AI
Pricing Contact for pricing
DeploymentOn-premise or cloud-based server
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Yes AI-estimated

Brainomix 360 Triage LVO (K231837) is an FDA-cleared notification tool. It provides real-time alerts of suspected large vessel occlusion (LVO) to clinicians by evaluating occlusions of the intracranial internal carotid artery (ICA) and proximal middle cerebral artery (M1 segment) on CT angiography scans.
Integrations
EHR Not specified
Specialties Emergency Medicine, Neurology, Radiology

What the Web Says

Brainomix 360 Triage LVO is an AI-powered software designed to assist clinicians in the rapid identification of large vessel occlusions (LVO) and intracranial hemorrhage (ICH) in acute stroke patients using non-contrast CT (NCCT) and CT angiography (CTA) scans. It aims to optimize workflow, facilitate faster treatment and transfer decisions, and ultimately improve patient outcomes by increasing access to life-saving treatments like mechanical thrombectomy. Physicians generally report improved confidence in treatment decisions and faster triaging due to the software.

Overall: Positive

Strengths

  • Rapid and reliable analysis of CT imaging in acute stroke settings.
  • Significantly increases rates of endovascular therapy (EVT) procedures and intravenous thrombolysis (IVT).
  • Reduces delays in patient triage and transfer.
  • Improves physician confidence in treatment decisions and speeds up triaging.
  • Associated with improved patient outcomes, including less severe disability at discharge.
  • Particularly beneficial in primary stroke centers and hospitals with fewer specialist doctors, expanding access to care.

Limitations

  • Should be used as an adjunct to expert interpretation, not a standalone decision-making tool.
  • Mobile app images are for informational purposes only and not for diagnostic use.
  • Not intended to be a rule-out device for LVO; all cases should undergo angiography per standard stroke workup.
  • Not intended for use in patients with recent neurosurgery, endovascular neurointervention, or previous stroke diagnosis within specified timeframes.
  • One real-world study indicated a poor positive predictive value (PPV) for e-CTA in consecutive cases in an NHS setting, advocating for local validation.
  • False positives can be caused by incorrect anatomy, other pathology, or calcification, while false negatives can occur with LVO within the terminal internal carotid artery (ICA).

Based on reviews from: Brainomix, NeuroNews, accessdata.fda.gov, MDPI, Diagnostic and Interventional Cardiology, PR Newswire, BioIndustry Association | BIA, PubMed, Reddit, AuntMinnieEurope, Google Play, Health Innovation Oxford and Thames Valley

Last updated: 2026-07-17

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Brainomix 360 Triage LVO

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

BIA
Brainomix expands to the US with FDA-cleared Stroke AI Platform
Brainomix launched its full suite of FDA-cleared modules in its Brainomix 360 platform for stroke care in the US, including Brainomix 360 Triage LVO, which provides real-time alerts for suspected large vessel occlusion. The platform aims to support clinicians in imaging-based treatment decisions across the stroke pathway.
2023-11
PR Newswire
Brainomix Targets US Expansion with the Launch of its Cutting-Edge Stroke AI Platform Following Series of FDA Clearances
Brainomix announced its continued US expansion with the launch of its FDA-cleared Brainomix 360 platform, which includes Brainomix 360 Triage LVO for real-time alerts of suspected large vessel occlusion. This launch follows several FDA clearances for modules within the platform.
2023-11
PR Newswire
Brainomix Launches Award-Winning Next Generation Stroke AI Platform with Novel Net Water Uptake Technology at the International Stroke Conference (ISC)
Brainomix launched its Brainomix 360 Next Generation platform at the International Stroke Conference, featuring new net water uptake technology and presenting research on the prospective performance validation of Brainomix 360 Triage LVO. The platform also received a Red Dot Design Award.
2026-02
Stroke (Journal of the American Heart Association)
Automated Vessel Occlusion Software in Acute Ischemic Stroke: Pearls and Pitfalls
This article discusses automated vessel occlusion software, including Brainomix 360 Triage LVO, which uses a two-stage machine learning approach to detect vessel occlusions and sends real-time alerts to clinicians. It highlights the importance of timely LVO identification for stroke triage and treatment.
2025-06
Medical Device Network
Brainomix expands into US territory with AI platform
Brainomix announced its US expansion with the launch of its FDA-cleared Brainomix 360 platform for stroke care, which includes Brainomix 360 Triage LVO for real-time alerts of suspected large vessel occlusion. The platform utilizes AI algorithms for real-time brain scan interpretation.
2023-11
accessdata.fda.gov
Brainomix 360 Triage LVO FDA 510(k) Clearance Letter
This FDA letter confirms the administrative change for Brainomix 360 Triage LVO, a radiological computer-aided triage and notification software, which was cleared on April 21, 2023. The device is intended to assist in prioritizing studies for reading within a worklist.
2024-06
Stroke (Journal of the American Heart Association)
Abstract TP237: Automated large vessel occlusion detection on CT angiography: a prospective comparison of two software packages
This study prospectively compared the performance of Brainomix 360 Triage LVO and Rapid LVO software packages for detecting large vessel occlusions on CT angiography in real-world use. The study found consistent performance between the two AI software devices.
2026-01
Cureus
Revolutionizing Acute Stroke Care: A Review of Food and Drug Administration-Approved Software as Medical Devices for Stroke Triage
This review article discusses FDA-approved software as medical devices for stroke triage, including Brainomix 360 Triage LVO, highlighting its role in detecting large vessel occlusions on CTA with high sensitivity and specificity. It emphasizes the impact of AI in reducing notification times and improving patient outcomes.
2024-11

Videos

Product demos, reviews, and walkthroughs for Brainomix 360 Triage LVO.

No videos found. Search YouTube directly

View all on YouTube

Frequently Asked Questions

Brainomix 360 Triage LVO is an FDA-cleared notification tool that provides real-time alerts of suspected large vessel occlusion (LVO) to clinicians, often directly to their smartphones. It evaluates occlusions on CT angiography scans and offers basic image viewing functions, aiming to optimize workflow across stroke networks and facilitate faster treatment and transfer decisions. This integration supports streamlined workflows, enabling fast, confident, and informed decision-making for patient management, including identifying candidates for mechanical thrombectomy.
Brainomix 360 Triage LVO is FDA-cleared and part of the broader Brainomix 360 Stroke platform, which is also CE-marked. Brainomix operates as a data processor, handling patient data on behalf of hospitals (the data controllers), and states adherence to GDPR articles 28 and 29, as well as being HIPAA compliant. The company is ISO 13485 and ISO 27001 certified, and processes data according to governance agreements and specific Data Processing Agreements with hospitals, with data held and processed within the UK and EU.
Brainomix 360 Triage LVO provides real-time alerts for LVO detection, which can improve the sensitivity, specificity, and accuracy of LVO detection compared to manual assessment, increasing clinician confidence and reducing time taken. While other platforms like RapidAI and Viz.ai also offer LVO detection, studies suggest varying performance metrics and volumetric discrepancies, indicating outputs are not always interchangeable. Brainomix has extensive validation for automated NCCT ASPECTS in triage, and AI platforms generally function as diagnostic safety nets and workflow optimizers.
Specific pricing models for Brainomix 360 Triage LVO are not publicly detailed in the search results. However, a health technology assessment assumed a price of $40 per patient for using AI software in ischemic stroke. Brainomix states that ongoing support is included with its Brainomix 360 platform, which can be deployed via on-premise VM, physical server, or cloud-based solutions, implying potential integration and maintenance considerations.
Brainomix 360 Triage Stroke (which includes LVO detection) is not intended for primary image interpretation or mobile diagnostic use, as images on mobile platforms are compressed preview images. It is not a rule-out device, and cases without notification should still undergo angiography per standard stroke workup; it also has limitations regarding patients with recent neurosurgery, endovascular neurointervention, or previous stroke within certain timeframes. Studies have shown that while sensitivity and specificity for LVO detection can be high, the positive predictive value can be lower, meaning a notable proportion of reported occlusions by the software could be false positives, and it may not detect isolated subarachnoid hemorrhage or symmetrical bilateral MCA occlusions.
Brainomix 360 Triage LVO is supported by a growing body of clinical evidence, including over 60 peer-reviewed studies validating the Brainomix 360 platform's performance and value. A large prospective observational study published in The Lancet Digital Health showed that implementing Brainomix 360 Stroke was associated with a 100% relative increase in mechanical thrombectomy rates and improved patient outcomes, including less severe disability at discharge. This evidence suggests the platform aids in identifying more eligible LVOs and streamlining transfers, particularly benefiting primary stroke centers.
Brainomix 360 Triage LVO is designed to detect occlusions of the intracranial internal carotid artery (ICA) and proximal middle cerebral artery (M1 segment) on CT angiography scans. However, its limitations include not being intended for detecting isolated subarachnoid hemorrhage or symmetrical bilateral MCA occlusions, and its performance for distal/MVO and posterior circulation occlusions can be more variable. The software is an assistive tool, and physicians retain the ultimate responsibility for diagnostic interpretation and treatment decisions, as it is not intended for primary interpretation and requires angiography for confirmation in suspected LVO cases.

Related Tools

Cercare Medical Oncology Virtual Expert
Cercare Medical
Neurology AI
Cercare Medical's Oncology Virtual Expert is an AI-powered brain tumor segmentation module that provides fast, consistent, and semi-automated tumor analysis from standard MRI data, designed for on-premise deployment within existing clinical radiology workflows.
CoLumbo C-Spine
Smart Soft Healthcare AD
Clinical Decision Support & Reference
CoLumbo C-Spine is an AI-powered software that processes and analyzes cervical spine MRI exams, assisting clinicians in diagnosis and assessment.
MeRT System
Wave Neuroscience
Mental & Behavioral Health AI
MeRT (Magnetic e-Resonance Therapy) is an advanced, personalized form of TMS that uses your own brainwave data to guide treatment. It's a non-invasive, drug-free option designed to help the brain communicate more efficiently so symptoms of conditions like depression, anxiety, PTSD, TBI, autism, and more can improve.
Paid
Brainomix 360 Hyperdensity
Brainomix Limited
Neurology AI
Brainomix 360 Hyperdensity is an AI-powered neuroimaging software tool that detects and quantifies brain hyperdensities on CT scans, forming a crucial part of the Brainomix 360 Stroke platform for rapid and accurate stroke assessment.
SOMNUM
HoneyNaps
Clinical Decision Support & Reference
SOMNUM is an AI-enabled medical software tool by Honeynaps Co., Ltd. that provides comprehensive sleep analysis to aid in the diagnosis and management of sleep disorders.
DETECT-ME/CFS project
DETECT-ME/CFS project (ME/CFS Research Foundation)
Clinical Decision Support & Reference
The DETECT-ME/CFS project is developing an AI-supported clinical decision support system to improve the rapid and reliable diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

See all Neurology AI tools →

More from Brainomix

Brainomix 360 e-ASPECTS
Brainomix Limited
Neurology AI
Brainomix 360 e-ASPECTS is an FDA-cleared and CE-marked AI decision support tool that automates and standardizes the ASPECTS score and measures ischemic signs on plain CT brain scans for acute stroke assessment.
Contact for pricing
Brainomix 360 e-CTA
Brainomix Limited
Clinical Decision Support & Reference
Brainomix 360 e-CTA is an AI-powered module within the Brainomix 360 Stroke platform that automates and standardizes the assessment of collaterals and detects large vessel occlusions on CT angiography scans for acute stroke patients.
Contact vendor
Brainomix 360 Hyperdensity
Brainomix Limited
Neurology AI
Brainomix 360 Hyperdensity is an AI-powered neuroimaging software tool that detects and quantifies brain hyperdensities on CT scans, forming a crucial part of the Brainomix 360 Stroke platform for rapid and accurate stroke assessment.
Brainomix 360 Triage ICH
Brainomix Limited
Neurology AI
Brainomix 360 Triage ICH is an FDA-cleared AI tool that provides real-time, smartphone-based alerts of suspected intracranial hemorrhage (ICH) from non-contrast CT scans, aiding rapid clinical triage and stroke treatment decisions.
Contact vendor

View company profile →

Suggest an Edit → | Last Verified: 2026-04-17 | First Added: 2026-04-17

Investors who backed Brainomix 360 Triage LVO

Funded through the company that built this tool.

Modi Ventures
VC T3
Houston, United States
unknown
Modi Ventures is an early-stage venture firm with a website and a LinkedIn presence that suggest a Texas-rooted, often Houston-area investor active…
AI/ML in Healthcare Biotech
AI Tool Finder
AI-powered search. Results may not be comprehensive.